EBS:NYSE
Emergent Biosolutions Inc
6,91 US$
0,00%
(0,00) 1D
6,78 US$
arrow_downward
-1,88% (-0,13)bedtimeJashtë orarit
Mbyllur: 14 tet, 4:00:03 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për EBS...
Hap
6,87 US$
I lartë
7,07 US$
I ulët
6,81 US$
Kapitalizimi i tregut
354,30 mln
Vëllimi mesatar
1,14 mln
Vëllimi
762,22 mijë
Maksimumi 52-javor
14,06 US$
Minimumi 52-javor
4,36 US$
Fitimet për aksion
-3,51 US$
Beta
2,28
Aksionet në qarkullim
51,27 mln
Numri i punonjësve
900
Hap
6,87 US$
I lartë
7,07 US$
I ulët
6,81 US$
Kapitalizimi i tregut
354,30 mln
Vëllimi mesatar
1,14 mln
Vëllimi
762,22 mijë
Maksimumi 52-javor
14,06 US$
Minimumi 52-javor
4,36 US$
Fitimet për aksion
-3,51 US$
Beta
2,28
Aksionet në qarkullim
51,27 mln
Numri i punonjësve
900
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Stocktwits
·
18 minuta më parë
S&P 500, Nasdaq See Worst Day In Over Two Months As Chipmaker Rout Deepens, CPI Data Comes In Hot — AAPL, SPCX, DRAM, SOXX In Focus
Yahoo Finance
·
42 minuta më parë
Invesco QQQ Doesn't Own a Single Bank, and That's Not the Only Thing the Nasdaq-100 Leaves Out
Simply Wall Street
·
37 minuta më parë
Lumentum Is Up 472% Even As It Swung To A Loss
Bloomberg.com
·
3 orë më parë
S&P 500 Ends Longest Streak of Calm Since 2020 as AI Trade Sinks
Profili
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Rreth Emergent Biosolutions Inc
Drejtori ekzekutivRobert G. Kramer Sr. | Joseph C. Papa
Punonjësit900
Themeluar më5 sht 1998
SeliaRockville, Maryland, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtiemergentbiosolutions.com